Suchergebnisse
Suchergebnisse:
2. Mai 2024 · Notable Works: “The Genetics of Cancer”. Subjects Of Study: APC. cancer. dicyclohexylcarbodiimide. genetics. p53. Bert Vogelstein (born June 2, 1949, Baltimore, Md., U.S.) is an American oncologist known for his groundbreaking work on the genetics of cancer.
- The Editors of Encyclopaedia Britannica
30. Apr. 2024 · The authors thank Prof. Bert Vogelstein from Johns Hopkins University, Maryland, US for providing the HCT116 p53 \(^{-/-}\) colon cancer cell line. The support from the Department of...
Vor 6 Tagen · “My intensive postdoctoral training at Johns Hopkins University, under the guidance of Dr. Bert Vogelstein in molecular oncology and genetics, really impacted my primary focus on molecular genetics of epithelial cancers and how we integrate large genomics data sets with biological and immunological data.”
2. Mai 2024 · Featured speakers include Padma Sheila Rajagopal, MD, MPH, a physician-scientist with the National Cancer Institute; Damaris Olagundoye, MD, a breast cancer survivor; Bert Vogelstein, MD, co-director of the Ludwig Institute at Johns Hopkins and director of the Lustgarten Dedicated Laboratory for Pancreatic Cancer Research at the ...
Vor 3 Tagen · There are series from Washington University in Saint Louis, Dana-Farber Cancer Center and the Broad Institute in Boston, and studies from Bert Vogelstein's lab at Johns Hopkins that have done whole genome sequencing on colon cancer. We are beginning to see that fewer than 200 genes are the major culprits in colon cancer. I think that ...
8. Mai 2024 · HHMI investigator Bert Vogelstein and colleagues at the Johns Hopkins Kimmel Cancer Center, in collaboration with investigators at Duke University and elsewhere, sequenced 20,661 genes in cells...
2. Mai 2024 · Clasp Therapeutics was created in response to a question posed by scientific co-founder Bert Vogelstein: How can tumour-specific characteristics be leveraged for a powerful immune system attack, while also sparing healthy tissues? The answer: T-cell engagers (TCEs) designed to lock onto a combined genetic-immune signature present ...
